On the basis of the results of previous studies, [28, 30, 31], we postulated that senescent stroma can contribute to disease progression by secreting inflammatory mediators, cytokines, and enzymes such as proteases, providing a mechanism through which p16-positive stroma contributes to tumor progression and/or invasion. This evidence concerns the gene CDKN2A and neoplasm.